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a b s t r a c t
The aim of the current work was to study the physico-chemical interactions of a bisphosphonate mole-
cule, risedronate, with a well-characterised synthetic nanocrystalline apatite (NCA) as a model bone min-
eral. We adopted a global approach, using complementary physico-chemical techniques such as FTIR,
RAMAN and NMR spectroscopies in order to learn more about the interaction process of risedronate with
the apatitic surface. The results obtained suggest that risedronate adsorption corresponds to an ion sub-
stitution reaction with phosphate ions occurring at the crystal surface. This mechanism explains the
greater amount adsorbed (N) for NCA, compared to well crystallised stoichiometric hydroxyapatite,
attributable to the well-developed hydrated layer at the surface of the nanocrystals. However, most cal-
cium ions remain attached to the solid phase and the formation of insoluble risedronate calcium salts
must also be considered as a competitive reaction to the adsorption. Thus a calcium risedronate salt
was synthesised and fully characterised for comparison to the solids after adsorption. Following spectro-
scopic results, it can be concluded that a strong interaction was established between risedronate ions and
calcium ions at the apatitic surface. However, under these experimental conditions there is no nucleation
of a distinct calcium risedronate salt and the apatite crystals retain their integrity.
1. Introduction
Bisphosphonates (BPs) are currently the most prescribed drugs
for the treatment of diseases involving bone disorders such as oste-
oporosis or Paget’s disease [1,2]. BPs are non-hydrolysable
analogues of pyrophosphate characterised by a structure in which
the oxygen bridge in pyrophosphate groups has been replaced by a
carbon with various side chains (P–C–P). Their mechanisms of
actionare related toboth their physicochemical andbiological activ-
ities. Like pyrophosphate, BPs present a high affinity for adsorption
onto apatite crystals due to the strong attraction of phosphonate
groups for calcium, and thereby prevent mineral dissolution and
bone resorption, inhibiting osteoclast activity [1,3]. Preclinical
studies with different BPs showed that these antiresorptive agents
not only inhibit bone loss, but can also increase bonemass and resis-
tance to fracture [2].
BPs are currently administered by a systemic route and, besides
their low bioavailability, generate some undesirable side effects
such as fever and gastrointestinal disturbances such as ulcers
[4,5]. Moreover, osteonecrosis of the jaw has been observed,
especially with intravenous preparations [6]. Thus, various investi-
gations have been performed to elucidate the molecular interac-
tions between BPs and bone or calcium phosphates compounds
to better understand their retention phenomena. Although some
studies have reported the release of phosphate ions during adsorp-
tion of several molecules, including BPs, suggesting an ion
exchange reaction, this phenomenon has rarely been quantified
and the adsorption process remains unclear. Mukherjee et al. [7]
showed, for example, that the binding of pamidronate onto bone
results in a strong chemisorption process, releasing one inorganic
phosphate per bisphosphonate bound [7]. The interaction of cal-
cium phosphate compounds with zoledronate appears to result
in a surface adsorption of the drug, driven by an ion-exchange
mechanism between phosphate and phosphonate groups on the
solid surface [8,9]. Cukrowski et al. [10] reported that etidronate
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molecules are adsorbed through binding of their phosphonate
groups to surface calcium sites of hydroxyapatite, as evidenced
by Raman and solid state NMR spectroscopy measurements.
Moreover several authors evidenced the great affinity of bisphos-
phonates for calcium ions to promote the precipitation of cal-
cium–BP salts [10–12]. The formation of calcium–BP complexes
or salts, resulting from the reaction of bone or calcium phosphates
with BP, was postulated but very few studies have been carried out
to prove it [10]. The formation of crystalline needles of calcium
zoledronate was observed in the case of the interaction of b-trical-
cium phosphate (b-TCP) with zoledronate in an aqueous medium
[13]. The formation of surface complexes was also reported for
the interaction of phosphoserine with hydroxyapatite [14].
Furthermore, most of these studies have generally focused on
well-crystallised calcium phosphates such hydroxyapatite (HA)
[15–17]. Only a few studies have been devoted to the interaction
of BPs with nanocrystalline apatites (NCA) analogous to bone min-
eral [18,19]. As for bone mineral, these supports have the particu-
larity to present a structured hydrated surface layer, as evidenced
by spectroscopic methods, that contains mineral ions in ‘‘non-
apatitic’’ environments easily exchangeable [20,21] and may affect
its surface properties [22]. Consequently, the aim of this work was
to study the physico-chemical interactions of a bisphosphonate
molecule, risedronate (Fig. 1), on a well-characterised synthetic
nanocrystalline apatite as a model bone mineral. The interaction
phenomena between risedronate molecules and the nanocrystals
were determined through adsorption reactions involving physico-
chemical characterisation of the solid and liquid, and were
compared with a well-crystallised stoichiometric hydroxyapatite.
To throw light on the possible formation of a separate phase in
the reacted apatite, the calcium salt of risedronate was synthes-
ised, fully characterised and compared with the sodium salt of
risedronate. For this, we adopted a global approach using comple-
mentary physico-chemical techniques such as FTIR, RAMAN and
NMR spectroscopies in order to learn more about the interaction
process of risedronate with the apatitic surface.
2. Materials and methods
2.1. Synthesis of apatite samples
A nanocrystalline carbonated apatite (NCA), analogous to bone
mineral, was prepared by a double decomposition reaction, at
physiologic pH, by mixing a cationic solution of Ca(NO3)24H2O
(0.29 M in 750 mL deionised water) and an anionic one containing
ammonium hydrogenophosphate and sodium bicarbonate (0.45 M
(NH4)2HPO4 and 0.71 M of NaHCO3 in 1500 mL deionised water)
[23]. The calcium solution was poured rapidly into the anionic
solution at room temperature (20 °C). The large excess of phos-
phate and carbonate ions used had a buffering effect and allowed
the pH to stabilise at around 7.4. The suspension was left to mature
at room temperature for 6 days without stirring and was then
filtered, washed with deionised water until free ammonium and
nitrate counter ions were eliminated, and then lyophilised.
The well crystallised stoichiometric hydroxyapatite (HA) was
synthesised by double decomposition between (NH4)2HPO4
(433.3 mL, 1.54 M in deionised water) and Ca(NO3)24H2O
(1100 mL, 1 M in deionised water). The phosphate solution was
added dropwise for about 3 h into the calcium solution maintained
at 90 °C under continuous stirring [24]; the pH of the suspension
was around 10. After filtration, the precipitate was washed and
lyophilised. Although stoichiometric hydroxyapatite has often
been used to study the adsorption properties of bioactive mole-
cules such as bisphosphonates, it appears rather different from
bone mineral, described as a non-stoichiometric nanocrystalline
apatite containing carbonate and/or hydrogen-phosphate ions.
HA was used in this study as a reference for synthetic apatite.
2.2. Preparation of the calcium salt of risedronate
The risedronate (1-hydroxy-2-(3-pyridinyl)ethylidene bisphos-
phonic acid monosodium hemipentahydrate salt, named BP) used
as adsorbate in this study was provided by Procter & Gamble Phar-
maceutical (Fig. 1). The calcium risedronate sample was prepared
by dropwise addition of a solution of calciumnitrate Ca(NO3)24H2O
(10 mL, 200 mM, pH = 6) into a solution of risedronate (25 mL,
40 mM, pH = 10); these reactants were dissolved in deionised and
decarbonated water with a calcium to risedronate molar ratio of
2:1. The mixture obtained (final pH = 9.7) was maintained under
stirring for 1 h at 25 °C and left to sit overnight in a closed vial.
The resulting precipitate, denoted as Ca2BP, was then filtered using
0.45 lm cellulose filters, washed with deionised decarbonated
water and dried at 37 °C for 20 h.
2.3. Adsorption experiments
Adsorption experiments were carried out at physiological tem-
perature (37 ± 1 °C), by dispersing 50 mg of apatite sample with
5 mL of risedronate solutions (concentration ranging from 0 to
12 mM) in a polyethylene tube. The latter were prepared by dis-
solving the appropriate amount of risedronate in an aqueous
1 mM KCl solution (standard solution); the pH of the obtained
solutions was adjusted to 7.4 using hydrochloric acid and potas-
sium hydroxide solutions. After sonication for 1–3 min, the sus-
pensions were incubated for 1 h without stirring and centrifuged
for 20 min at 5000 rpm. This equilibration time was previously
determined from kinetic experiments using risedronate concentra-
tions of 0.86 and 1.41 mM for HA and NCA, respectively (data not
shown). Blanks containing only the adsorbate, prepared and incu-
bated in the solutions corresponding to the adsorption tests but
without apatite solid, were used as controls.
After centrifugation, the solids obtained were washed with
deionised water and lyophilised. The supernatants were filtrated
on 0.2 lm Millipore filters.
2.4. Solution analysis
The phosphate content of the solutions obtained after adsorption
was determined by colorimetry of phospho-vanado-molybdic acid
at 460 nm (Hewlett Packard 8452A Diode Array Spectrophotome-
ter). The quantity of calcium ions was measured by inductively
coupled plasma atomic emission spectroscopy (ICP-AES, Horiba,
Jobin Yvon, 2004, Ultima 2).
The risedronate concentration in the filtrates was determined
using UV spectrophotometric absorption at 262 nm (Hewlett
Packard 8452A Diode Array Spectrophotometer). This wavelength
corresponds to the maximum absorbance of the pyridine group.
The calibration curve ranged from 0 to 0.43 mM. The molar absorp-
tion coefficient deduced from all calibration curves obtained was
approximately 3.77  103 L molÿ1 cmÿ1 (±0.13  103 L molÿ1
cmÿ1) at pH 7.4. This value is close to that reported (3.90  103
L molÿ1 cmÿ1 at pH 7) in the literature [25].
Fig. 1. Molecular structure of 1-hydroxy-2-(3-pyridinyl)ethylidene bisphosphonic
acid monosodium hemipentahydrate salt.
The quantity of risedronate adsorbed Q (mol/m2) was then
determined from the relation:
Q ¼ VðDCÞ=W ð1Þ
where V (L) is the volume of the solution in contact with W (g) of
apatite, and DC (mol/L) is the difference between the initial and
final equilibrium concentrations of risedronate. The values for the
amounts of risedronate adsorbed by NCA and HA, performed in
triplicate, were reproducible within a range of 5%.
2.5. Solid phases characterisation
2.5.1. X-ray diffraction
The solid phases were characterised by X-ray diffraction (CPS
120 INEL) using the Ka1 radiation of a cobalt anticathode
(k = 1.78892 Å). Apparent crystallite sizes were calculated from
the (002) and (310) lines using the Scherrer’s equation [26].
2.5.2. FTIR spectroscopy
The infrared spectrum of each powder was recorded over the
400–4000 cmÿ1 range with a Thermo Nicolet 5700 Fourier-trans-
form infrared (FTIR) spectrometer (2 mg sample/300 mg KBr).
Curve fittings in the m4PO4 domain were performed using
GRAMS/386 software. The band shape was considered Lorentzian
in all instances and the baseline was always linear, fixing or vary-
ing parameters (position and width) to provide the best curve fit.
The relative band integrated intensities were defined as the ratio
of the peak area to the total area of the phosphate bands.
2.5.3. Raman spectroscopy
Raman spectra of the samples were generated on a Horiba,
Jobin-Yvon Labram HR800 confocal microspectrometer, equipped
with a helium–neon LASER (k = 632.82 nm). The spectral resolution
was 2 cmÿ1, the laser power was 2 mW and integration times var-
ied from 30 to 120 s. All spectra were recorded over a wavelength
range of 200–1800 cmÿ1. Three spectral accumulations were
averaged.
2.5.4. 31P solid state NMR
31P Single Pulse Excitation (SPE)–Magic Angle Spinning (MAS)
measurements were done at 242.47 MHz with a Bruker ASX 500
NMR spectrometer operating in a static field of 11.7 T. A sample
powder was filled into a 4 mm zirconia rotor and spun at 12 kHz.
The recycle delay was 200 s for all the measurements, in accor-
dance with the 31P spin lattice relaxation times measured by
saturation. The number accumulation was 32. The 31P chemical
shifts were referenced to an external standard aqueous 85%
H3PO4 solution.
2.6. Chemical analysis of samples
The composition of the solids was determined after dissolution
in nitric acid. Calcium content was determined by complexometry
with EDTA and phosphate content by UV spectrophotometry at
460 nm (Single beam UV/Vis Hitachi U-1100 spectrophotometer)
using phospho-vanado-molybdic acid [27]. The relative error in
the level of calcium and phosphate was 0.5% at. The determination
of the atomic Ca/P ratio of the precipitate had a relative error of 1%
at. The quantity of carbonate ions in the NCA sample was measured
by coulometry (UIC, Inc. CM 5014 coulometer with CM 5130
acidification unit).
2.7. Specific surface area
The specific surface area of the investigated samples was
measured by nitrogen adsorption according to the BET method
(Quantachrome NOVA-1000 Ver 3.70).
2.8. Thermogravimetric analyses
Thermogravimetric analyses (TGA-DTA) were performed using
a Setaram Instrumentation SETSYS evolution system, with a heat-
ing rate of 3 °C/min, from 25 °C to 500 °C (30.00 ± 0.01 mg of each
sample).
2.9. Transmission electron microscopy
Transmission electron microscopy (TEM) micrographs were re-
corded in the secondary electron mode on a JEOL JEM 2100F
microscope set at an acceleration tension of 200 kV.
3. Results and discussion
3.1. Characterisation of HA and NCA samples
Chemical analyses for NCA and HA gave Ca/P ratios of 1.53 and
1.64 (±0.01), respectively, and determined the level of carbonate at
4.5% wt. (±0.5%) for NCA.
Fig. 2 shows X-ray diffraction (XRD) diagrams of the solids
synthesised. The X-ray diffraction pattern of the HA sample corre-
sponded to a well crystallised apatitic phase, while the NCA sample
exhibited broad peaks illustrating the poorly crystalline feature of
the apatitic phase prepared. The latter pattern appeared very anal-
ogous to those observed for bone samples [28]. No additional crys-
talline phase was detected. The mean crystallite dimensions
derived from Scherrer’s formula applied to apatitic diffraction lines
(002) and (310) were evaluated for HA and NCA:L(002) was equal
to 57.4 and 29.5 nm (±0.5 nm), and L(310) values were 27.5 and
9.0 nm (±0.5 nm), respectively. These values confirm that apatitic
crystals were elongated along the c axis of the hexagonal structure
of the apatite (L(002) > L(310)) [28]. The crystal dimension appeared
smaller for the nanocrystalline apatite sample than for HA. These
results were confirmed by TEM observation (Fig. 3).
The specific surface areas were evaluated at 59 m2/g (±0.5%) for
HA and 201 m2/g (±0.5%) for NCA. The specific surface area of NCA
appears about 3.4 times higher than that of HA sample in agree-
ment with TEM and XRD results.
Fig. 2. XRD diagrams of the synthesised hydroxyapatite (HA) and nanocrystalline
apatite (NCA) compared with bone mineral.
The FTIR spectrum of HA showed bands corresponding to apat-
itic calcium phosphate compounds (Fig. 4A): PO3ÿ4 vibration bands
at 550–600 cmÿ1 (m4), 961 cm
ÿ1 (m1) and 1000–1100 cm
ÿ1 (m3), and
OH bands at 630 and 3560 cmÿ1, characteristic of an apatitic envi-
ronment [29]. The weak band at 875 cmÿ1 can be assigned to
HPO2ÿ4 ions, confirming that the powder is a slightly calcium-defi-
cient HA, in accordance with the chemical analyses. The infrared
spectrum of NCA exhibited broader phosphate bands and no OH
vibration was observed. Additional bands were evidenced in the
m4PO4 domain (Fig. 4B) by curve fitting analysis, corresponding to
non-apatitic environments of PO3ÿ4 (620 cm
ÿ1) and HPO2ÿ4
(530 cmÿ1) ions present in the hydrated surface layer [30]. More-
over, the presence of CO3 vibrations was observed at 871, 1419
and 1476 cmÿ1 [20]. Type A and type B apatitic environments
and labile species [31] could also be seen by curve fitting in the
m2CO3 domain (data not shown). These results confirm the pres-
ence of labile phosphate and carbonate ions in a hydrated surface
layer of NCA that has been shown to be able to undergo exchange.
Raman spectra of the HA and NCA powders synthesised (Fig. 5)
showed characteristic lines of apatite phosphate groups in
accordance with the FTIR studies: the m1 (960 cm
ÿ1), m2 (430–
450 cmÿ1), m3 (1040–1074 cm
ÿ1), and m4 (590–608 cm
ÿ1) modes
of PO3ÿ4 [22]. For NCA, additional CO
2ÿ
3 vibration mode was
detected at 1073 cmÿ1 (m1) attributable to type B carbonate substi-
tutions [32]. These lines overlapped the m3 of PO
3ÿ
4 .
The 31P SPE-MAS solid NMR spectra of HA and NCA are shown in
Fig. 6. The spectrum of HA shows a characteristic thin line at
2.6 ppm corresponding to orthophosphate species [33], whereas
the spectrum of NCA presents a single asymmetric broad line at
3.3 ppm due to the presence of HPO2ÿ4 in the apatite lattice [22].
3.2. Adsorption experiments
A kinetic study performed under the same experimental condi-
tions revealed that the equilibrium concentration of risedronate ad-
sorbed by HA and NCA crystals was reached in less than 20 min
(data not shown). Therefore an incubation period of 1 h was applied
in the adsorption experiments. The evolution of the amount of risedr-
onate adsorbed from the diluted solutions (0–12 mM) as function of
the equilibrium concentration in the solution is plotted in Fig. 7.
The isotherms obtained exhibited a typical Langmuirian shape. Simi-
lar observations have been noted for the interactions of various bis-
phosphonates [16,34,35] and other biological molecules with
apatite crystals [17,36,37]. The adsorption plateaus were reached at
relatively low risedronate concentrations (initial concentration less
than 1.5 mM), indicating a high affinity between the risedronatemol-
ecules and the mineral surface. A slight increase in pH values (up to
0.3 unit) was noticed during risedronate adsorption. The parameters
of adsorption can be deduced from the Langmuir equation:
Q ¼
KNCe
ð1þ KCeÞ
ð2Þ
The term Q corresponds to the amount of risedronate adsorbed
(lmol/m2), Ce is the equilibrium concentration in the solution
(mmol/l), N is the maximum amount adsorbed at saturation (lmol/
m2), and K is the affinity constant (L/mmol). The latter is only an
Fig. 3. TEM observation of (A) HA and (B) NCA.
(A)
(B)
Fig. 4. (A) FTIR spectra of hydroxyapatite (HA) and nanocrystalline apatite (NCA) and (B) the corresponding decomposition in the m4PO4 domain.
apparent parameter as the process is not completely reversible, as
previously described [38]. The parameters of the isotherms (K and
N) were determined by linear regression using the following linear-
ised equation:
Ce=Q ¼ Ce=N þ 1=KN ð3Þ
Thecorrelationcoefficientobtainedover theentire rangeofconcentra-
tions investigated was high (r2 > 0.99). The surface area occupied by
one molecule of risedronate (r), calculated from the values of N and
the specific surface area of the solids,was on the order of 0.7 nm2/mol-
ecule forHAand0.5 nm2/molecule forNCA. Table 1 gives the results of
adsorption parameters obtained for risedronate and other bisphos-
phonates reported in the literature for comparative purposes
[34,35], such as etidronate (1-hydroxyethylene-1,1-disphosphonate)
and pamidronate (3-amino-1-hydroxy-1-phosphonopropanediphospho-
nate). Theaffinity constants (K) were significantly higherwith respect
to our experimental data, probably due to difference in the properties
of the HA powder used. As shown in our study, the HA surface cannot
be fully covered by bisphosphonate molecules, and the authors sup-
posed that the area occupied by one molecule is determined by the
strong electrostatic interaction between the molecules of BP ad-
sorbed. This interaction can be explained by the negative charge of
the BP groups and is enhanced by the presence of the hydroxyl group
attached to the central carbon and/or the positive charge of the pro-
tonatedaminogroup.Hence, the interactiondependson thenatureof
the bisphosphonate as shown by Mukherjee et al. [7]. Moreover,
other authors assume that water molecules play an important role
in the adsorptionmechanism. Vitha et al. [34] consider that the apat-
itic support is solvated by a layer of water molecules and that the
adsorption equilibrium can be described as a competition between
adsorbed/free water and BP moieties on the surface of the crystals.
Hence, a decrease in the localwater concentration could favour affin-
ity for the apatitic surface. This explanation, however, neglects the
fact that the bonding of watermolecules to BP is probably totally dif-
ferent, as shown by other studies.
Nevertheless, this hypothesis could explain the difference in
adsorption parameters observed between HA and NCA supports.
The lower affinity constant (K) observed for NCA compared to HA
could be attributed to the presence of a hydrated layer at the
surface of the nanocrystals. Furthermore, the higher adsorption
capability (N) observed for the NCA sample with respect to HA
can also be attributed to this well-developed hydrated layer con-
taining relatively labile mineral ions [22]. Other factors such as
the crystallinity index, chemical composition and crystal size
may also influence the adsorption behaviour of such bioactive
molecules on the apatitic support. Similar observations have been
reported for the interaction of different bioactive species with
calcium phosphates [36,37,39].
Fig. 5. Raman spectra of the risedronate sodium salt (BP), risedronate calcium salt (Ca2BP), hydroxyapatite and nanocrystalline apatite powders before (HA and NCA) and
after uptake of risedronate (HA/BP and NCA/BP).
3.3. Analysis of the solutions after uptake of risedronate
Analyses of the solutions obtained after uptake of bisphospho-
nate revealed that the binding of risedronate ions to the apatite
surface affected the amount of calcium and phosphate ions in the
solution. The evolution of these ions in solution as a function of
risedronate adsorbed onto NCA is plotted in Fig. 8. The release of
phosphate ions increased linearly (slope close to 1) upon uptake
of risedronate. The content of phosphate ions in solution for the
poorly crystalline sample (NCA) was significantly higher, due to
the specific solubility behaviour of this type of apatite. Conversely,
it was reported that the addition of phosphate ions to the medium
inhibited the uptake of different anionic molecules [40,41] due to
their competition for adsorbing sites on the apatite surface. These
observations suggest that risedronate molecules substituted for
phosphate ions on the mineral surface. As proposed by several
authors [8,9,18] for other BPs, it can be postulated that risedronate
species participate in an ionic exchange process with active min-
eral ions on the surfaces of apatite crystals, particularly phosphates
and/or carbonates, which share the same ionic sites at the crystal
surface. This mechanism explains the higher uptake of NCA
compared to HA (Table 1); this effect is attributed to the
well-developed hydrated layer with relatively mobile mineral ions
characteristic of non-apatitic environments on the surface of the
nanocrystals [22]. The BP molecules adsorbed on bone minerals
can only be detached from the mineral by the reverse action of
phosphate ions and/or competitive adsorbing species.
Other phenomena determining the mineral ion concentrations
in the solution, such as dissolution of the apatite and maturation
and formation of ions pairs and/or soluble calcium complexes in
the solution, or the formation of bisphosphonate calcium salts,
must also be considered. In particular, it has been noted that
adsorption of risedronate weakly influences the calcium content
of the solution: the amount of calcium in the solution remained
very low (<10 ppm) and increased only slightly at high risedronate
concentrations (Fig. 8). Remembering that the content of free cal-
cium ions in the solution is related to the phosphate level and is
determined by the solubility equilibrium of the apatite, this weak
increase in the level of calcium ions in the solution at elevated
phosphate contents is difficult to explain because the solubility
equilibrium of the apatite should then lead to a decrease in free
calcium ions in solution. One possible explanation could be the for-
mation of a soluble calcium complex or ion pairs involving risedr-
onate molecules. Moreover, most calcium ions remain attached to
the solid phase and the formation of insoluble risedronate calcium
salts must also be considered a competing reaction to adsorption
and compared to the solids after adsorption. To throw light on
the possible formation of surface complexes in the reacted apatite,
the prepared calcium salt of risedronate was characterised and
compared with the risedronate sodium salt (BP) and the apatite
samples obtained after uptake of risedronate (HA/BP and NCA/BP).
3.4. Characterisation of the risedronate calcium salt
XRD diagrams of the sodium risedronate salt used as adsorbate
and the prepared calcium salt of risedronate are shown in Fig. 9.
Sodium risedronate presents an XRD diagram similar to the data
reported for the hemipentahydrate form of monosodium risedro-
nate [42,43]. The crystal system determined in the literature is a
monoclinic cell with unit cell dimensions of: a = 21.7463 Å,
b = 8.9667 Å; c = 15.1193 Å, Z = 8, space group C2/c. The XRD data
recorded for the Ca2BP precipitate clearly show an amorphous
phase.
A thermogravimetric analysis was performed from 25 °C to
300 °C (data not shown) to provide information on the hydration
level of the solids. Three weight losses were observed in the TG
curve for the risedronate monosodium hemipentahydrate salt, at
about 75, 145 and 195 °C, corresponding to a total weight loss of
12.8% and 2.5 water molecules of hydration. These results are in
accordance with data reported in the literature: the first loss is
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Fig. 6. 31P SPE-MAS NMR spectra of the risedronate sodium salt (BP), risedronate
calcium salt (Ca2BP), hydroxyapatite and nanocrystalline apatite powders before
(HA and NCA) and after uptake of risedronate (HA/BP and NCA/BP).
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Fig. 7. Adsorption isotherms of risedronate onto hydroxyapatite (HA), (h) and
nanocrystalline apatite (NCA), (s) at pH 7.4 and T 37 °C. The data fit the Langmuir
isotherm.
consistent with channel-type water of hydration, and the loss
above 140 °C corresponds to a lattice-type water of hydration
[42,43]. The TG curve of the synthesised risedronate calcium salt
showed a single weight loss at about 90 °C, corresponding to a total
weight loss of about 10% or about 2 water molecules of hydration
per risedronate molecule.
The results of the chemical analyses of the risedronate calcium
salt gave a Ca/BP ratio of 1.94 (close to 2) suggesting that two
calcium ions reacted with one risedronate molecule. Such amor-
phous solids were also obtained in the case of a 2:1 calcium–HEDP
(1-hydroxyethylidene-1,1-disphosphonic acid) precipitation [11].
The solubility constant of the calcium salt of risedronate was not
found in the literature. However, regardless of the Ca/BP ratio
being close to 2 in the solid, the dissociation equilibrium of risedr-
onate (Fig. 10), [16,44,45] at the experimental pH used (pH around
10), and taking into account the decrease in pH observed during
the reaction process (final pH = 9.7), the main precipitation reac-
tion can be described as follows:
2Ca2þ þHBP3ÿ¡Ca2BPþH
þ ð4Þ
Thus, the precipitation mechanism results in a stable neutral salt
occurring when each calcium attacks two hydrogen atoms on each
phosphonate group of BP and replaces the deprotonating species,
such as proposed by Browning and Fogler for the interaction be-
tween calcium and HEPD (1-hydroxyethylidene-1,1-diphosphonic
acid) [11] and applied in Fig. 11 for the synthesised risedronate
calcium salt.
The infrared spectra of the monosodium risedronate compared
to that of the calcium risedronate precipitate (Ca2BP) exhibited
significant differences (Fig. 12). FTIR vibrations for a hemipentahy-
drated form of the monosodium risedronate salt were fully ex-
plained by Redman-Furey et al. [42]. The spectrum showed two
distinct OH stretching bands at 3557 and 3614 cmÿ1 indicative of
two different water populations within the crystal lattice. The
shoulder observed at 3333 cmÿ1 is attributed to a COAH vibration
corresponding to OH groups not associated with water but at-
tached to the central carbon. Neither of these OH vibration bands
were observed in the spectrum of the calcium risedronate salt.
Only a broad band assigned to the OH bond of the CAOH group
was observed in the 3350 cmÿ1 region while the bands at about
3550–3600 cmÿ1 disappeared, indicating that water was removed
from the crystal lattice as previously observed by thermal analysis.
Similar observations have been done for other risedronate metal
complexes [46].
Hydroxyl vibrations from OH groups associated with the
O@PAOH of the phosphonate group produced broad bands in the
spectral region between 1600 and 2725 cmÿ1 for the risedronate
sodium salt, but not in the Ca2BP spectrum because of the deproto-
nation of these OH groups and the binding with calcium ions.
The characteristic infrared bands of the phosphonate group
(PO3) were observed between 1000 and 1150 cm
ÿ1 for the risedr-
onate sodium salt, overlapping with pyridine ring vibrations. They
were shifted to a higher frequency (Dm  50 cmÿ1) for the calcium
salt, evidencing the strong interaction of phosphonate groups with
calcium in the synthesised Ca2BP. This band is relatively broad in
accordance with the low crystallinity observed by XRD.
Fig. 5 presents Raman spectra in the region between 200 and
1800 cmÿ1 of the monosodium risedronate salt and the synthes-
ised calcium salt. The broader bands that are observed in the Ca2BP
spectrum, compared to those of the sodium salt, are related to the
amorphous state revealed by XRD. The Raman spectra of both the
sodium and calcium salts are dominated by vibration bands asso-
ciated with the substituted pyridine ring in the chemical structure
between 1000 and 1650 cmÿ1 [42].
Table 1
Adsorption parameters of bisphosphonates on NCA and HA at pH 7.4: maximum amount adsorbed at saturation (N) and apparent affinity constant (K) derived from Langmuir-
type equation plots.
Adsorbent Bisphosphonate Nmass ± DN (lmol/g) Nsurface ± DN (lmol/m
2) K ± DK (L/mmol) Area/moleculea (r) (nm2)
NCA Risedronate 643 ± 60 3.2 ± 0.3 2.1 ± 1.0 0.5
HA Risedronate 136 ± 6 2.3 ± 0.1 7.3 ± 3.6 0.7
HA Etidronate 189c 1.58 ± 5.00b 55.0 ± 3.9b 3.3c 0.8–1.0b
HA Pamidronateb 1.82 ± 7.00b 44.0 ± 10.0b 0.8–1.0b
a
r = S/Na, where Na is Avogadro’s number and S is the surface area of the adsorbent.
b From Ref. [34].
c From Refs. [1,35].
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Fig. 8. Correlation between phosphate (j) and calcium (4) ions released in
solution and risedronate adsorbed onto synthesised nanocrystalline apatite (1 mM
KCl solution at pH 7.4 and T 37 °C). The phosphate content in solution appears
linearly dependent on the amount of adsorbed risedronate, while the calcium
content shows very faint variations. The results concerning HA were previously
published [17,38].
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Fig. 9. XRD diagrams of the synthesised sodium (BP) and calcium salt (Ca2BP) of
risedronate.
The risedronate sodium salt showed two intense bands in the
1025–1055 cmÿ1 region assigned toCAHpyridine ring deformation,
strongly impacted by hydrogen bonding between the pyridine ring
and an adjacent phosphate group [42]. These bands were shifted
to 1035 and 1050 cmÿ1, respectively, in the Ca2BP form, possibly
due tomodifications in the hydrogenbonding involving thepyridine
group and the adjacent phosphonate group in the calcium salt.
In the 1450–1700 cmÿ1 spectral region, the Raman spectrum of
BP showed a medium band at 1637 cmÿ1 with a shoulder at
1625 cmÿ1 and a weaker one at 1445 cmÿ1 associated with the
substituted pyridine ring, while two bands were observed for
Ca2BP at higher frequencies, 1596 and 1582 cm
ÿ1, showing a
change in the environment of the substituted pyridine ring
induced by calcium binding. Pyridine rings do not participate in
the coordination to calcium ions. However, the pyridine nitrogen
participates in hydrogen bonding, as previously reported for differ-
ent hydrates of risedronate [43,46].
The characteristic Raman bands of the phosphonate groups
(PO3) in the risedronate sodium salt were observed at 862, 932,
970, 1196 and 1222 cmÿ1 [10]. These vibration bands were also
shifted after the interaction with calcium, towards lower wave-
numbers at 849, 914, 967, 1188 and 1229, respectively; this may
be explained by changes in the PAO environments due to probable
coordination with Ca2+, slightly larger than the sodium ion, induc-
Fig. 10. Chemical structures and dissociation of risedronate (Hp represents the proton linked to the nitrogen atom in the pyridine ring) depending on the values of
equilibrium dissociation constants pKas from the literature [16,44,45].
Fig. 11. Chemical structure proposed for the synthesised calcium risedronate salt
(Ca2BP).
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Fig. 12. FTIR spectra of the monosodium risedronate salt (BP) and the calcium salt (Ca2BP).
ing a shift to higher frequencies, as observed by other authors for
risedronate metal complexes [46].
The spectrum of the sodium salt showed two bands at 629 and
661 cmÿ1, related to the m(CAP) bond stretching vibration [10].
These bands were shifted to 642 and 677 cmÿ1 in the Ca2BP spec-
trum, due to the strong interaction between phosphate and
calcium.
The 31P SPE-MAS NMR spectrum of the risedronate sodium salt
exhibited two distinct and slightly resolved lines at 19.01 and
17.12 ppm (Fig. 6) characteristic of the hemipentahydrated form
of risedronate [42,43]. These lines are attributable to the two phos-
phonate groups resulting from the non-centrosymmetric crystal
structures [47,48]. For the synthesised risedronate calcium salt,
only a broad line appears at c.a. 18 ppm. Similar results have been
reported by Grossmann et al. [15] and Mukherjee et al. [7] for
adsorption of various bisphosphonates on synthetic hydroxyapatite
and bone. The line broadening reflects a change in the electronic
environment of the 31P of the two phosphonate groups resulting
from their interaction with calcium ions. This interaction could
explain the amorphous structure of the sample as evidenced by
XRD.
3.5. Characterisation of the solids after uptake of risedronate
FTIR spectra recorded for the solids after uptake of bisphospho-
nate and for the synthesised risedronate calcium salt are shown in
Fig. 13. It can be seen that FTIR spectra of samples treated with
risedronate solutions generated additional vibration bands before
900 cmÿ1 attributable to PAC vibration [49]. The three bands cen-
tred at about 679, 714 and 801 cmÿ1 are stronger in the NCA
spectrum compared with HA, probably due to the greater amount
of risedronate adsorbed compared with HA. These bands are pres-
ent in the spectrum of the synthesised Ca2BP; however, the posi-
tions of the two first bands for the risedronate sodium salt are
shifted, respectively, to 690 cmÿ1 and 747 cmÿ1, while the latter
band at 801 cmÿ1 was split. The perceptible change in the infrared
spectra of the solids incubated with BP solutions is evidence that
the bisphosphonate molecules interact with the calcium ions on
the apatitic surface.
The Raman spectra of apatite samples before and after uptake of
risedronate and for the risedronate calcium salt are illustrated in
Fig. 5. Additional bands were observed for both apatitic minerals
upon interaction with risedronate molecules. Like in the FTIR spec-
tra, these bands are stronger in the NCA spectrum compared with
HA, due to the greater adsorption capability of risedronate for the
nanocrystals as evidenced by the adsorption isotherms. The char-
acteristic Raman bands of the phosphonate group (PO3) of risedro-
nate between 850 and 1250 cmÿ1 were covered by the vibration
bands of the orthophosphate group (PO4) in the apatitic structure;
only the band at about 1040 cmÿ1 and two weaker ones at 808 and
858 cmÿ1 were observed. In addition, additional bands in the
vibrational domain of the pyridine ring were detected: a broad
band at 1596 cmÿ1 in the HA spectrum, and a split one at 1588
and 1603 cmÿ1 in the NCA spectrum, associated with the substi-
tuted pyridine ring, visible in the Ca2BP spectrum and shifted
towards lower frequencies in the spectrum of the risedronate
sodium salt. Two weaker bands were observed at 646 and
677 cmÿ1, attributable to CAP vibrations, and others between
1150 and 1500 cmÿ1 due to pyridine ring quadrant stretches; these
bands are also similar to those noticed in the Ca2BP spectrum and
shifted with respect to the risedronate sodium salt. In accordance
with the FTIR results, the characterisation of the supports after up-
take with risedronate by Raman spectroscopy evidences a strong
interaction of the risedronate molecules with calcium ions on the
surface of the solids, regardless of the amounts adsorbed and the
nature of the apatitic support.
The 31P SPE-MAS spectra of the sample powders after uptake of
risedronate, compared to those before contact and to that of the
synthesised risedronate calcium salt (Fig. 6), reveal a weak broad
line centred at 18 ppm attributable to 31P nuclei present in the
two phosphonate groups. This observation is evidence for the pres-
ence of risedronate species on the apatite surface. The broadness of
this line, which is very different from that in the risedronate
sodium salt, suggests a lack of crystallinity as proposed by
Grossmann et al. for the interaction of some bisphosphonates with
hydroxyapatite [15]. Such a broad line is also present in the 31P
NMR spectrum of the synthesised risedronate calcium salt,
whereas two thinner separated lines were observed for the sodium
salt.
Regardless of the results of the characterisation of the apatitic
solids uptake of risedronate comparedwith the calcium–risedronate
salt, a strong interaction exists between risedronate and calcium at
the surface of the apatite samples. The analysis of the solutions after
interaction with risedronate shows that most calcium ions remain
attached to the solid phase and the formation of insoluble risedro-
nate calcium saltsmust also be considered as a competitive reaction
to the adsorption, even if the solubility of this compound is un-
known. Indeed, spectroscopic characterisation of the apatite sup-
ports the existence of vibrational bands present in the synthesised
Ca2BP spectrum. The reaction on the apatitic surface could then be
described as a dissolution–reprecipitation phenomenon. Such reac-
tions have been previously proposed, for example in the adsorption
of zoledronate [9], andwere representedbyPascaudet al. [18] by the
following equation:
CaXðPO4Þsolid þ ðX=2ÞBP
4ÿ
solution ! X=2Ca2BPsolid þ ðPO4Þ
2Xÿ
solution ð5Þ
where X is the Ca/P ratio of the apatite and (PO4) phosphate species
(undetermined protonation states). In the case of a dissolution–
reprecipitation phenomenon and the formation of a Ca2BP salt,
the amount of phosphate released versus risedronate remaining in
solution would be equal to 2/X, i.e. 1.31 for NCA. However the
Preleased/BP ratio obtained in this study for NCA appears close to 1,
which would exclude the formation of a calcium salt of Ca2BP. Fur-
thermore, other arguments can exclude the dissolution–reprecipita-
tion phenomenon. No other phase was detected by XRD although
the calcium risedronate salt is amorphous and difficult to detect
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Fig. 13. FTIR spectra in the 660–850 cmÿ1 domain of the risedronate sodium salt
(BP), the synthesised calcium salt (Ca2BP), hydroxyapatite (HA) and nanocrystalline
apatite (NCA) after uptake of risedronate (NCA/BP and HA/BP) at pH 7.4 and 37 °C.
by this technique. Similarly, we could not observe foreign phases by
SEM (data not shown). Furthermore, it should be noted that a disso-
lution–reprecipitation reaction would not lead to a Langmuir
adsorption equilibrium in the range of concentrations explored. If
risedronate calcium salts were formed as a separate phase, the
phosphate released would continue to increase with the increase
in risedronate in the solution and no plateau would be reached.
Under these experimental conditions there is no nucleation of a
distinct calcium risedronate salt and the apatite crystals retain their
integrity. On the basis of these experimental observations the main
driving force still seems to be an ion-exchange process involving
risedronate species and active mineral ions of the apatite crystals,
particularly phosphate.
Besides, previous studies concerning the reversibility of the
adsorption process [38] have shown a strong interaction between
risedronate and apatitic surface as the adsorption of bisphospho-
nate molecules is irreversible with respect to dilution and the
amount adsorbed is not altered by dilution of the adsorption
solution or even on washing of the samples.
However, based on the spectroscopic results, a strong interac-
tion between risedronate and calcium at the surface of the apatite
samples seems to exist. The shifts of vibration bands observed can
be attributed to BP/apatitic mineral interactions. These interac-
tions modify the molecular environment and can be explained by
the creation of bonds between different moieties of BP and the
apatitic surface, in particular the pyridine nitrogen from risedro-
nate and phosphate groups from the apatite. Such results are in
agreement with recent studies suggesting that the 3-D configura-
tion of amino-bisphosphonates (N-BPs), such as zoledronate and
risedronate, and the orientation of their nitrogen play an important
role in apatitic mineral binding affinity [2]. 3-D computational
modelling was tested to examine the potential for additional inter-
actions of the nitrogen moiety in the N-BPs and suggested that
some N-BPs can form NAHAO hydrogen bonds on the HA surface
[50]. Such bonds could involve changes in the pyridine ring envi-
ronments of risedronate and modify its vibrational modes, which
explain shifts observed in the Raman spectra.
Moreover in a previous study concerning tiludronate adsorption
on an apatitic surface [18] a binding mechanism was proposed
involving both phosphate substitution and interaction with cal-
cium groups of the HA surface, in two steps: (1) an interaction of
a BP molecule with Ca2+ ions on the apatitic surface involving par-
tial or total deprotonation of phosphonate groups; (2) the released
protons interact with surface hydrogen phosphate groups, yielding
H2PO
ÿ
4 ions, which are then released. Supported by the results ob-
tained in this study, a third step could be added in the case of
risedronate: (3) nitrogen bonding of a BP molecule with an OH
group on the apatite surface and the formation of an NAHAO bond.
4. Conclusion
This study suggests that risedronate adsorption on apatitic
supports corresponds to an ion substitution reaction with phos-
phate ions at the crystal surface. Thismechanism explains the great-
er amount adsorbed (N) for NCA, compared to the HA specimen,
attributed to thewell-developed hydrated layer with relativelymo-
bilemineral ions at the surface of the nanocrystals corresponding to
nonapatitic environments. However,most calcium ions remain thus
attached to the solid phase, and the formation of insoluble risedro-
nate calcium saltsmust also be considered as a competitive reaction
to the adsorption. Thus, a calcium risedronate salt was synthesised
and fully characterised for comparison with the solids after adsorp-
tion. Following the spectroscopic results, it can be concluded that a
strong interaction is established between risedronate ions and cal-
cium ions at the surface of the apatite samples. However under
these experimental conditions there is no nucleation of a distinct
calcium risedronate salt and the apatite crystals maintain their
integrity.
The combination of FTIR, Raman and solid NMR spectroscopies
proved to be a powerful multidisciplinary approach for under-
standing the interaction of nanocrystalline apatites as a model of
bone mineral and bisphosphonate molecules.
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